Combination of nucleoside analogues tiazofurin and ribavirin downregulates experimental autoimmune encephalomyelitis

Annals of the New York Academy of Sciences

Volumn 1048, Issue , 2005, Pages 392-395

  Lavrnja, Irena ^a   Stojkov, Danijela ^a   Peković, Sanja ^a   Šubašić, Sanja ^a   Mostarica Stojković, Marija ^b   Stošic Grujičić, Stanislava ^a   Nedeljković, Nadežda ^a   Medić Mijačević, Ljubica ^c   Rakić, Ljubisav ^a   Stojiljković, Mirjana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Institute for Research and Development   (Yugoslavia)

Author keywords

EAE; Ribavirin; Spinal cord; Tiazofurin

Indexed keywords

FREUND ADJUVANT; NUCLEOSIDE DERIVATIVE; RIBAVIRIN; TIAZOFURIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HISTOPATHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; RAT; RAT STRAIN; SPINAL CORD; TISSUE HOMOGENATE;

AGOUTI; ANIMALIA;

EID: 25144432808     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1342.047     Document Type: Conference Paper

References (13)

1. LORENTZEN, J.C. et al. 1995. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. J. Neuroimmunol. 63: 193-205.
2. HOHLFELD, R. 1997. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 120: 865-916.
3. FRANCHETTI, P. et al. 1996. IMP dehydrogenase as a target of antitumor and antiviral chemotherapy. IL Farmaco 51: 457-469.
4. YAMADA, Y. et al. 1988. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase. Biochemistry 27: 2193-2196.
5. STOSIC-GRUJICIC, S. et al. 2002. Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin. J. Neuroimmunol. 130: 66-77.
6. MILICEVIC, I. et al. 2003. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats. J. Neurosci. Res. 72: 268-278.
7. NATSUMEDA, Y. et al. 1989. Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells. Biochem. Biophys. Res. Commun. 153: 321-327.
8. PRAJDA, N. et al. 1993. Sequential impact of tiazofurin and ribavirin on enzymic program of the bone marrow. Cancer Res. 53: 9519-9523.
9. PEAVY, D.L. et al. 1980. Inhibition of lymphocyte proliferative response by ribavirin. Infect. Immun. 29: 583-589.
10. TRAN, G.T. et al. 2001. Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis. Int. Immunopharmacol. 1: 1709-1723.
11. HEAGY, W. et al. 1991. Inhibition of immune functions by antiviral drugs. J. Clin. Invest. 87: 1916-1924.
12. ALLISON, A.C. & E.M. EUGUI. 2000. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47: 85-118.
13. PANKIEWICZ, K.W. 1999. Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents. Exp. Opin. Ther. Patents 9: 55-65.